المؤلفون: Christian H. Nolte, Martin Ebinger, Katja Zieschang, Kersten Villringer, Hebun Erdur, Serdar Tütüncü, Sabina Kaczmarek, Benjamin Winter, Heinrich J. Audebert, Matthias Endres, Ulrike Grittner, Frederik Geisler, Kerstin Bollweg, Jan F. Scheitz, Matthias Wendt, Michal Rozanski, Alexander Kunz, Joachim E. Weber, Carolin Waldschmidt, Jochen B. Fiebach

المصدر: The lancet / Neurology 15(10), 1035-1043 (2016). doi:10.1016/S1474-4422(16)30129-6

مصطلحات موضوعية: pharmacology [Fibrinolytic Agents], Male, Pediatrics, medicine.medical_specialty, medicine.medical_treatment, statistics & numerical data [Mobile Health Units], statistics & numerical data [Registries], 030204 cardiovascular system & hematology, Brain Ischemia, 03 medical and health sciences, administration & dosage [Tissue Plasminogen Activator], 0302 clinical medicine, Fibrinolytic Agents, Modified Rankin Scale, administration & dosage [Fibrinolytic Agents], Health care, Outcome Assessment, Health Care, Medicine, Humans, ddc:610, Registries, Stroke, statistics & numerical data [Hospitalization], Aged, business.industry, pharmacology [Tissue Plasminogen Activator], Odds ratio, Thrombolysis, Middle Aged, medicine.disease, drug therapy [Stroke], Clinical trial, Hospitalization, Tissue Plasminogen Activator, Emergency medicine, drug therapy [Brain Ischemia], Observational study, Female, Neurology (clinical), business, 030217 neurology & neurosurgery, Fibrinolytic agent, Mobile Health Units

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::200c3cd072c77b94c9af80f860637a8e
https://pubmed.ncbi.nlm.nih.gov/27839644